All Comments by Alexei Koudinov

  1. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
  2. Alzheimer's disease: plaques and tangles.
  3. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
  4. Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry.
  5. Barriers to drug discovery and development for Alzheimer disease.
  6. Barriers to Alzheimer disease drug discovery and development in academia.
  7. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
  8. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
  9. Parkinson's disease: one biochemical pathway to fit all genes?
  10. The treatment of Alzheimer's disease: where have we been, and where are we going?
  11. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
  12. Apolipoproteins and aging: emerging mechanisms.
  13. Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases.
  14. Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine.
  15. By the way, doctor. I read in the paper that cholesterol might be good for the brain and prevent Alzheimer's disease. So I'm wondering if taking a statin is really such a good idea.